Talha Badar, Hematology/Oncology specialist at Mayo Clinic, shared a post on X:
“ALL CART presentation by Dr. Bijal Shah.
-
Bridging therapy before CAR-T based on Ph status and disease burden.
-
Brexucel vs Obecel based on age, prior CAR-T/alloHCT and CD19 expression.”
